1. Home
  2. VECO vs NVAX Comparison

VECO vs NVAX Comparison

Compare VECO & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Veeco Instruments Inc.

VECO

Veeco Instruments Inc.

HOLD

Current Price

$29.44

Market Cap

1.9B

Sector

Technology

ML Signal

HOLD

Logo Novavax Inc.

NVAX

Novavax Inc.

HOLD

Current Price

$6.75

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VECO
NVAX
Founded
1945
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
1.1B
IPO Year
1994
1995

Fundamental Metrics

Financial Performance
Metric
VECO
NVAX
Price
$29.44
$6.75
Analyst Decision
Buy
Hold
Analyst Count
6
8
Target Price
$28.00
$9.75
AVG Volume (30 Days)
670.8K
3.3M
Earning Date
11-05-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.83
2.07
Revenue
$681,408,000.00
$1,064,651,000.00
Revenue This Year
N/A
$58.91
Revenue Next Year
$9.81
N/A
P/E Ratio
$35.26
$3.22
Revenue Growth
N/A
20.27
52 Week Low
$16.92
$5.01
52 Week High
$34.45
$11.55

Technical Indicators

Market Signals
Indicator
VECO
NVAX
Relative Strength Index (RSI) 43.73 43.34
Support Level $28.70 $6.36
Resistance Level $33.41 $6.76
Average True Range (ATR) 1.28 0.22
MACD -0.27 0.05
Stochastic Oscillator 10.83 47.39

Price Performance

Historical Comparison
VECO
NVAX

About VECO Veeco Instruments Inc.

Veeco Instruments Inc is a United States-based company engaged in designing, developing, and manufacturing thin-film process equipment, mainly used for producing electronic devices. The company focuses on semiconductor process equipment that addresses a range of challenging materials engineering problems for its customers. Its products include Laser Processing Systems, Lithography Systems, Ion Beam Systems, SiC CVD Systems, MOCVD Systems, Wet Processing Systems, MBE Technologies, Atomic Layer Deposition Systems, Physical Vapor Deposition Systems, Dicing and Lapping Systems, as well as Gas & Vapor Delivery Systems. The majority of the company's revenue is generated from sales to the Semiconductor Industry and within China.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

Share on Social Networks: